Boston Family Office’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Hold |
12,397
| – | – | ﹤0.01% | 284 |
|
|
2025
Q1 | $32K | Hold |
12,397
| – | – | ﹤0.01% | 279 |
|
|
2024
Q4 | $51K | Hold |
12,397
| – | – | ﹤0.01% | 273 |
|
|
2024
Q3 | $88K | Hold |
12,397
| – | – | 0.01% | 275 |
|
|
2024
Q2 | $81K | Hold |
12,397
| – | – | 0.01% | 264 |
|
|
2024
Q1 | $103K | Hold |
12,397
| – | – | 0.01% | 261 |
|
|
2023
Q4 | $136K | Hold |
12,397
| – | – | 0.01% | 257 |
|
|
2023
Q3 | $104K | Hold |
12,397
| – | – | 0.01% | 251 |
|
|
2023
Q2 | $156K | Hold |
12,397
| – | – | 0.01% | 256 |
|
|
2023
Q1 | $204K | Hold |
12,397
| – | – | 0.02% | 256 |
|
|
2022
Q4 | $185K | Sell |
12,397
-350
| -3% | -$5.22K | 0.02% | 264 |
|
|
2022
Q3 | $286K | Hold |
12,747
| – | – | 0.03% | 229 |
|
|
2022
Q2 | $214K | Hold |
12,747
| – | – | 0.02% | 258 |
|
|
2022
Q1 | $382K | Hold |
12,747
| – | – | 0.03% | 226 |
|
|
2021
Q4 | $391K | Buy |
12,747
+350
| +3% | +$10.7K | 0.03% | 230 |
|
|
2021
Q3 | $391K | Sell |
12,397
-8,724
| -41% | -$275K | 0.03% | 222 |
|
|
2021
Q2 | $773K | Hold |
21,121
| – | – | 0.06% | 175 |
|
|
2021
Q1 | $730K | Hold |
21,121
| – | – | 0.05% | 177 |
|
|
2020
Q4 | $878K | Hold |
21,121
| – | – | 0.07% | 168 |
|
|
2020
Q3 | $900K | Buy |
+21,121
| New | +$900K | 0.08% | 154 |
|